Madison Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Madison Wealth Management's PFE Position: Q3 2023 in Review
Madison Wealth Management reduced its Pfizer (PFE) stake by 4.7% in Q3 2023, selling an estimated $69.4K and leaving 40,160 shares worth $1.33M. The position accounts for 0.28% of the portfolio, ranked #89.
Madison Wealth Management first reported a position in PFE in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.27M in Q4 2021. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Madison Wealth Management held 40,160 shares of Pfizer worth $1.33M as of Q3 2023.
- Madison Wealth Management sold 1,963 Pfizer shares in Q3 2023, an estimated $69.4K.
- Pfizer made up 0.28% of Madison Wealth Management's portfolio in Q3 2023, its #89 holding.
- Madison Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 16 quarters since.
- Madison Wealth Management's Pfizer position peaked at $2.27M in Q4 2021.
- 2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Madison Wealth Management's 13F filing for Q3 2023, filed 7 Nov 2023.